To see and compare the effect of ultrasound therapy versus add on effect of tila oil janubasti followed by ultrasound therapy

A Randomized Controlled Clinical Study of Add on effect of Tila Tail Janubasti Followed by Ultrasound Therapy versus Ultrasound Therapy Alone in Pain Management of Janusandhigat Vata with Special Reference to Knee Osteoarthritis - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086785

Enrollment

Registered

2025-05-13

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M17- Osteoarthritis of knee

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Janusandhigat Vata and exhibiting classical signs and symptoms of knee osteoarthritis are eligible for the study. The specific criteria are: 1. Both male and female patients. 2. Patients aged between 30 and 60 years. 3. Radiological evidence of osteoarthritis of the knee joint. 4. Presence of pain and restricted movement in the knee joint. 5. Presence of at least one of the following: crepitus, pain, or swelling of the knee joint. 6. Patients must be suitable for Sweda (sudation) therapy. 7. Patients must be eligible for ultrasound therapy. 8. Patients should be willing to adhere to the treatment protocol and follow-up assessments. 9. Patients must provide informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with rheumatoid arthritis, rheumatic fever, rheumatic heart disease, gouty arthritis, psoriatic arthritis, or sciatica. 2. Patients with congenital or acquired abnormalities affecting the knee joint. 3. Patients with recent or ongoing fractures (simple or compound), ACL tears, or other trauma- related injuries affecting the knee joint. 4. Patients with a known history of immune-compromised conditions. 5. Patients suffering from infectious conditions such as tuberculosis (TB), carcinoma, or other serious infections. 6. Patients undergoing systemic steroid therapy or other immunosuppressive treatments. 7. Patients with active local skin infections or dermatitis over the knee joint. 8. Patients with severe cardiovascular, renal, or hepatic conditions that could interfere with the treatment or assessment. 9. Pregnant or breastfeeding women. 10. Patients with a history of allergic reactions to any of the components used in the treatments.

Design outcomes

Primary

Measure	Time frame
sandhishoolaTimepoint: 7 days	—

Secondary

Measure	Time frame
Akunchan - prasaran vedana, atop, sandhishothaTimepoint: 7 days	—

Countries

India

Contacts

Public ContactDr Vishwajeet Patade

APMs ayurved mahavidyalaya, sion

drvishup@gmail.com9869055701

Outcome results